-
1
-
-
0032828179
-
Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
-
Rix M, Andreassen H, Eskildsen P et al. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 1999; 56: 1084-1093.
-
(1999)
Kidney Int
, vol.56
, pp. 1084-1093
-
-
Rix, M.1
Andreassen, H.2
Eskildsen, P.3
-
2
-
-
0037058829
-
Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis
-
Proudfoot D, Davies JD, Skepper JN et al. Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 2002; 106: 3044-3050.
-
(2002)
Circulation
, vol.106
, pp. 3044-3050
-
-
Proudfoot, D.1
Davies, J.D.2
Skepper, J.N.3
-
3
-
-
0035158822
-
Atherogenic high-fat diet reduces bone mineralization in mice
-
Parhami F, Tintut Y, Beamer WG et al. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 2001; 16: 182-188.
-
(2001)
J Bone Miner Res
, vol.16
, pp. 182-188
-
-
Parhami, F.1
Tintut, Y.2
Beamer, W.G.3
-
4
-
-
0032079445
-
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
-
Bucay N, Sarosi I, Dunstan CR et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-1268.
-
(1998)
Genes Dev
, vol.12
, pp. 1260-1268
-
-
Bucay, N.1
Sarosi, I.2
Dunstan, C.R.3
-
5
-
-
0037144676
-
SB 242784, a selective inhibitor of the osteoclastic V-H+ATPase, inhibits arterial calcification in the rat
-
Price PA, June HH, Buckley JR et al. SB 242784, a selective inhibitor of the osteoclastic V-H+ATPase, inhibits arterial calcification in the rat. Circ Res 2002; 91: 547-552.
-
(2002)
Circ Res
, vol.91
, pp. 547-552
-
-
Price, P.A.1
June, H.H.2
Buckley, J.R.3
-
6
-
-
0035723970
-
Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D
-
Price PA, June HH, Buckley JR et al. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 2001; 21: 1610-1616.
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 1610-1616
-
-
Price, P.A.1
June, H.H.2
Buckley, J.R.3
-
7
-
-
0035036363
-
Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption
-
Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 2001; 21: 817-824.
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 817-824
-
-
Price, P.A.1
Faus, S.A.2
Williamson, M.K.3
-
8
-
-
33750220360
-
Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate
-
Price PA, Roublick AM, Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006; 70: 1577-1583.
-
(2006)
Kidney Int
, vol.70
, pp. 1577-1583
-
-
Price, P.A.1
Roublick, A.M.2
Williamson, M.K.3
-
9
-
-
61349180704
-
Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure
-
Lomashvili KA, Moni er-Faugere M-C, Wang X et al. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int 2009; 75: 617-625.
-
(2009)
Kidney Int
, vol.75
, pp. 617-625
-
-
Lomashvili, K.A.1
Moni er-Faugere, M.-C.2
Wang, X.3
-
10
-
-
33847275569
-
Prevention of aortic calcification by etidronate in the renal failure rat model
-
Tamura K, Suzuki Y, Matsushita M et al. Prevention of aortic calcification by etidronate in the renal failure rat model. Eur J Pharmacol 2007; 558: 159-166.
-
(2007)
Eur J Pharmacol
, vol.558
, pp. 159-166
-
-
Tamura, K.1
Suzuki, Y.2
Matsushita, M.3
-
11
-
-
3142654694
-
Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients
-
Hashiba H, Aizawa S, Tamura K et al. Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients. Ther Apher Dial 2004; 8: 241-247.
-
(2004)
Ther Apher Dial
, vol.8
, pp. 241-247
-
-
Hashiba, H.1
Aizawa, S.2
Tamura, K.3
-
12
-
-
4544291461
-
Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis
-
Nitta K, Akiba T, Suzuki K et al. Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 2004; 44: 680-688
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 680-688
-
-
Nitta, K.1
Akiba, T.2
Suzuki, K.3
|